Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Kevin M. Sheehan | Director | 2025-08-15 | 10,511 | $18.72 | $196.77kSell |
Kevin M. Sheehan | Director | 2025-07-30 | 21,801 | $30.51 | $665.15kSell |
Tarun Lal | Chief Executive Officer | 2025-07-22 | 8,060 | $31.26 | $251.92kBuy |
Darin Harper | Chief Financial Officer | 2025-06-24 | 1,010 | $31.86 | $32.18kSell |
Darin Harper | Chief Financial Officer | 2025-06-24 | 134 | $31.86 | $4.27kSell |
Darin Harper | Chief Financial Officer | 2025-06-24 | 1,010 | $3.19k | $3.22MSell |
Darin Harper | Chief Financial Officer | 2025-06-24 | 134 | $31.86 | $4.27kSell |
Darin Harper | Chief Financial Officer | 2025-06-24 | 134 | $31.86 | $4.27kSell |
Darin Harper | Chief Financial Officer | 2025-06-24 | 1,010 | $3.19k | $3.22MSell |
John Mulleady | SVP RE Dev | 2025-06-17 | 5,931 | $32.79 | $194.46kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Hill Path D Fund LP | 20.55% | 7,124,015 | $129.37M | Insider |
Hill Path Capital Partners LP | 20.55% | 7,124,015 | $129.37M | Insider |
Hill Path Capital LP | 20.54% | 7,119,255 | $129.29M | Institution |
Blackrock Inc | 11.66% | 4,043,332 | $73.43M | Institution |
Vanguard Group Inc | 8.79% | 3,048,011 | $55.35M | Institution |
Eminence Capital LP | 8.38% | 2,905,454 | $52.76M | Institution |
Patient Capital Management LLC | 6.15% | 2,133,287 | $38.74M | Institution |
Morgan Stanley | 4.19% | 1,451,842 | $26.37M | Institution |
Goldman Sachs Group Inc | 4.04% | 1,400,558 | $25.43M | Institution |
Barrow Hanley Mewhinney Strauss LLC | 3.96% | 1,371,546 | $24.91M | Institution |